查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1963826

心臟定位设备市场－全球产业规模、份额、趋势、机会、预测：按类型、适应症、最终用途、地区和竞争格局划分，2021-2031年

Cardiac Mapping Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Indication, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球心臟定位设备市场预计将从 2025 年的 29.9 亿美元成长到 2031 年的 56.9 亿美元，复合年增长率为 11.32%。

这些诊断设备在电生理手术中至关重要，它们利用导管感测器来收集并分析心臟的电讯号。透过建立精确的3D心腔模型，医生可以准确地识别复杂心律不整（例如心房颤动）的解剖起源。这些设备提供的即时电讯号数据对于引导消融导管到达引起心律不整的特定组织至关重要，有助于改善心臟治疗效果，从而提升患者的预后。

市场概览
预测期 2027-2031
市场规模：2025年 29.9亿美元
市场规模：2031年 56.9亿美元
复合年增长率：2026-2031年 11.32%
成长最快的细分市场 关于心臟定位系统的咨询
最大的市场 北美洲

市场成长的主要驱动力是全球心血管疾病的增加以及易患心律不整的老年人口不断增长。此外，临床上向依赖精准导航的微创消融技术的转变也进一步推动了这项需求。欧洲心臟学会预测，到2025年，全球三分之一的人在其一生中的某个阶段将面临可能危及生命的心律不整。然而，儘管临床需求迫切，但实施和维护这些系统的高昂成本对医疗基础设施发展中资金有限的地区构成了重大障碍，阻碍了市场成长。

市场驱动因素

心血管疾病和心律不整盛行率的不断上升是市场成长的主要驱动力。随着心房颤动等复杂心律不整发生率的增加，迫切需要能够进行根治性消融手术的先进标测系统。这种流行病学负担导致手术数量增加，并对精准诊断工具的需求日益增长。根据美国心臟协会 (AHA) 发布的《2024 年心血管疾病与中风统计》报告，心血管疾病仍是全球首要死因，每年约夺去 1,991 万人的生命。此外，美国国家心肺血液研究所 (NHLBI) 估计，到 2024 年，至少有 1,055 万美国成年人将患有心房颤动，是先前预测的三倍。

同时，3D电解剖标测与人工智慧融合的技术突破也正在推动市场发展。业界领导者正迅速部署高密度多电极导管和人工智慧驱动的软体，这些软体能够自动检测导致心律不整的基材，从而提高手术效率。这些创新直接满足了复杂电生理病例中对精准度的临床需求。这些新一代科技的商业性化应用显然十分活跃。例如，雅培在2024年10月的财报中宣布，其电生理业务销售额实现了14.3%的有机成长。这项业绩主要得益于心臟定位产品两位数的成长，这印证了业界正向先进、技术复杂的诊断解决方案转型。

市场挑战

心臟定位系统的购置和维护需要大量投资，这极大地阻碍了市场发展。高昂的初始投资往往是一个难题，尤其对于发展中地区的医疗机构。此外，专用导管和技术维护的持续成本也加剧了这一障碍，显着增加了整体拥有成本。因此，资金有限的医院常常推迟技术升级或继续依赖过时的方法，这直接限制了可安装的标测设备数量，并减少了这些地区製造商的潜在收入来源。

这些经济限制因素导致临床需求与实际技术应用之间存在显着差距。虽然需要心律不整管理的患者人数不断增加，但医疗预算的财政限制阻碍了这些设备的广泛应用。世界心臟联盟（WHF）预测，到2024年，心血管疾病将导致全球约2,050万人死亡，凸显了有效干预工具的紧迫性。然而，预算拨款往往难以承担先进标测技术的高昂价格，使得製造商难以进入价格敏感型市场，减缓了整个产业的成长速度。

市场趋势

心臟定位和脉衝电场消融(PFA) 技术的融合正在迅速改变竞争格局。随着 PFA 系统因其能够快速、非热消融肺静脉而日益受到临床青睐，标测平台也在不断发展，以实现与这些创新导管的无缝整合。这种技术协同作用能够精确地可视化导管位置并评估病灶持久性，同时避免了传统射频消融方法所需的逐点精细标测。这种融合的影响是巨大的。根据 MedTech Dive 2024 年 10 月报道，波士顿科学公司第三季电生理相关销售额年增 177%，这一增长主要归功于市场对与该公司 PFA 系统兼容的标测工具的强劲需求。

同时，业界正朝着非接触式、非侵入式标测解决方案发展。这些方案旨在透过在插入导管前利用表面电极和先进的计算模型重建心臟的三维电生理图，从而简化手术流程并提高安全性。这种方法显着缩短了术中标测所需的时间，并最大限度地减少了患者接受电离辐射的风险。为了展示此调查方法的实际应用优势，Vector Medical 于 2024 年 4 月发布了研究成果。根据这些研究结果，与标准治疗相比，其基于人工智慧的非侵入式标测技术将心律不整消融手术中的透视时间缩短了 43.7%。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球心臟定位设备市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依类型（接触式心臟定位系统、非接触式心臟定位系统）
    • 适应症（心房颤动、心房扑动等）
    • 透过申请（医院、诊断中心等）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美心臟定位设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲心臟定位设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区心臟定位设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲心臟定位设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲心臟定位设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章 全球心臟定位设备市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Abbott
  • Biosense Webster
  • Boston Scientific
  • Siemens Healthineers
  • Medtronic
  • Acutus Medical
  • Boston Scientific
  • GE Healthcare
  • Philips
  • MicroPort

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 26642

The Global Cardiac Mapping Devices Market is projected to expand from USD 2.99 Billion in 2025 to USD 5.69 Billion by 2031, registering a CAGR of 11.32%. These diagnostic instruments are essential in electrophysiology procedures, utilizing catheter-based sensors to capture and analyze the heart's electrical signals. By generating precise three-dimensional models of cardiac chambers, these systems allow physicians to accurately identify the anatomical sources of complex arrhythmias, such as atrial fibrillation. The real-time electrical data provided by these tools is critical for guiding ablation catheters to the specific tissues responsible for irregular heartbeats, thereby enhancing treatment efficacy and improving patient outcomes in cardiac care.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.99 Billion
Market Size 2031USD 5.69 Billion
CAGR 2026-203111.32%
Fastest Growing SegmentContact Cardiac Mapping Systems
Largest MarketNorth America

Market growth is largely fueled by the rising global burden of cardiovascular diseases and an aging population that is increasingly prone to rhythm disorders. This demand is further supported by a clinical shift toward minimally invasive ablation techniques, which rely on precise navigational capabilities. According to the European Society of Cardiology, projections for 2025 indicate that one in three individuals worldwide will face a potentially life-threatening heart rhythm disorder during their lifetime. However, despite this urgent clinical need, the market encounters significant obstacles due to the high costs associated with acquiring and maintaining these systems, which restricts their accessibility in developing healthcare infrastructures with limited financial resources.

Market Driver

The increasing prevalence of cardiovascular diseases and arrhythmias serves as a primary catalyst for market momentum. As the incidence of complex rhythm disorders like atrial fibrillation rises, there is a critical need for advanced mapping systems to facilitate curative ablation procedures. This epidemiological burden results in higher procedural volumes and a growing demand for accurate diagnostic tools. The American Heart Association's "2024 Heart Disease and Stroke Statistics" report indicates that cardiovascular disease continues to be the leading cause of global mortality, claiming approximately 19.91 million lives annually. Furthermore, the National Heart, Lung, and Blood Institute estimated in 2024 that at least 10.55 million American adults are expected to suffer from atrial fibrillation, a figure three times higher than previous predictions.

Concurrently, the market is propelled by technological breakthroughs in 3D electro-anatomical mapping and the integration of artificial intelligence. Industry leaders are rapidly deploying high-density multi-electrode catheters and AI-driven software that automate the detection of arrhythmogenic substrates, thereby improving procedural efficiency. These innovations directly address the clinical demand for precision in complex electrophysiology cases. The strong commercial adoption of these next-generation technologies is evident; for instance, Abbott reported in their October 2024 results that Electrophysiology sales grew by 14.3 percent on an organic basis, a performance driven specifically by double-digit growth in cardiac mapping products, confirming the industry's shift toward sophisticated, tech-enabled diagnostic solutions.

Market Challenge

The substantial financial investment required to purchase and sustain cardiac mapping systems constitutes a major restraint on market progression. Healthcare facilities, particularly those in developing regions, often find the initial capital expenditure prohibitive. This barrier is compounded by recurring expenses for specialized catheters and technical maintenance, which significantly increases the total cost of ownership. Consequently, hospitals with limited funding often postpone technology upgrades or rely on conventional methods, directly limiting the installed base of mapping units and reducing potential revenue streams for manufacturers in these territories.

This economic constraint creates a distinct gap between clinical necessity and actual technology adoption. While the patient population requiring arrhythmia management is expanding, the financial rigidity of healthcare budgets limits the penetration of these devices. According to the World Heart Federation, cardiovascular diseases caused approximately 20.5 million deaths globally in 2024, underscoring the urgent need for effective intervention tools. However, because budget allocations often cannot accommodate the premium pricing of advanced mapping technologies, manufacturers face difficulties expanding into price-sensitive markets, thereby slowing the overall growth trajectory of the industry.

Market Trends

The convergence of cardiac mapping with Pulsed Field Ablation (PFA) technologies is rapidly reshaping the competitive landscape. As PFA systems become clinically preferred for their ability to deliver rapid, non-thermal pulmonary vein isolation, mapping platforms are evolving to ensure seamless integration with these innovative catheters. This technological synergy allows for precise visualization of catheter placement and assessment of lesion durability without the extensive point-by-point mapping required by traditional radiofrequency methods. The impact of this integration is profound; MedTech Dive reported in October 2024 that Boston Scientific saw a 177% increase in third-quarter electrophysiology sales year-over-year, a surge attributed primarily to the high demand for its PFA system and compatible mapping tools.

Simultaneously, the industry is witnessing a shift toward non-contact and non-invasive mapping solutions designed to streamline procedural workflows and enhance safety. These advanced systems employ body-surface electrodes and sophisticated computational modeling to reconstruct 3D electrical maps of the heart before invasive catheters are introduced. This approach significantly reduces the time required for intra-procedural mapping and minimizes patient exposure to ionizing radiation. Validating the operational benefits of this methodology, Vektor Medical published study results in April 2024 showing that their AI-based non-invasive mapping technology led to a 43.7% reduction in fluoroscopy duration during arrhythmia ablation procedures compared to the standard of care.

Key Market Players

  • Abbott
  • Biosense Webster
  • Boston Scientific
  • Siemens Healthineers
  • Medtronic
  • Acutus Medical
  • Boston Scientific
  • GE Healthcare
  • Philips
  • MicroPort

Report Scope

In this report, the Global Cardiac Mapping Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiac Mapping Devices Market, By Type

  • Contact Cardiac Mapping Systems
  • Non-Contact Cardiac Mapping Systems

Cardiac Mapping Devices Market, By Indication

  • Atrial Fibrillation
  • Atrial Flutter
  • Others

Cardiac Mapping Devices Market, By End-use

  • Hospitals
  • Diagnostic Centers
  • Others

Cardiac Mapping Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiac Mapping Devices Market.

Available Customizations:

Global Cardiac Mapping Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiac Mapping Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems)
    • 5.2.2. By Indication (Atrial Fibrillation, Atrial Flutter, Others)
    • 5.2.3. By End-use (Hospitals, Diagnostic Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Cardiac Mapping Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Indication
    • 6.2.3. By End-use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cardiac Mapping Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By End-use
    • 6.3.2. Canada Cardiac Mapping Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By End-use
    • 6.3.3. Mexico Cardiac Mapping Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By End-use

7. Europe Cardiac Mapping Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Indication
    • 7.2.3. By End-use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cardiac Mapping Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By End-use
    • 7.3.2. France Cardiac Mapping Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By End-use
    • 7.3.3. United Kingdom Cardiac Mapping Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By End-use
    • 7.3.4. Italy Cardiac Mapping Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By End-use
    • 7.3.5. Spain Cardiac Mapping Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By End-use

8. Asia Pacific Cardiac Mapping Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Indication
    • 8.2.3. By End-use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cardiac Mapping Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By End-use
    • 8.3.2. India Cardiac Mapping Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By End-use
    • 8.3.3. Japan Cardiac Mapping Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By End-use
    • 8.3.4. South Korea Cardiac Mapping Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Indication
        • 8.3.4.2.3. By End-use
    • 8.3.5. Australia Cardiac Mapping Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Indication
        • 8.3.5.2.3. By End-use

9. Middle East & Africa Cardiac Mapping Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Indication
    • 9.2.3. By End-use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cardiac Mapping Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By End-use
    • 9.3.2. UAE Cardiac Mapping Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By End-use
    • 9.3.3. South Africa Cardiac Mapping Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By End-use

10. South America Cardiac Mapping Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Indication
    • 10.2.3. By End-use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cardiac Mapping Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By End-use
    • 10.3.2. Colombia Cardiac Mapping Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By End-use
    • 10.3.3. Argentina Cardiac Mapping Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cardiac Mapping Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Biosense Webster
  • 15.3. Boston Scientific
  • 15.4. Siemens Healthineers
  • 15.5. Medtronic
  • 15.6. Acutus Medical
  • 15.7. Boston Scientific
  • 15.8. GE Healthcare
  • 15.9. Philips
  • 15.10. MicroPort

16. Strategic Recommendations

17. About Us & Disclaimer